Navigation Links
Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock

WESTBURY, N.Y., April 1, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that its Board of Directors has authorized a share repurchase program of up to $1.5 million of the Company's common stock. As of Friday, March 29, 2013, this would represent approximately 5% of the total outstanding shares of Vasomedical common stock.

"We have the capital resources available to implement a fairly aggressive stock repurchase program such as this, which amounts to roughly 5% of our total outstanding shares, and still invest in our company's business to drive future growth. We believe that our share price does not properly reflect the current value of our business or its potential future performance," said Dr. Jun Ma , President and Chief Executive Officer of Vasomedical, Inc. "We have a strong financial profile that gives us the flexibility to focus on our future plans to grow sales and achieve profitability, while supporting our stock. We believe this strategy shows our commitment to building shareholder value as well as confidence in achieving long-term growth."  

The share repurchase program is effective immediately. Repurchases will be made in accordance with applicable securities laws in the open market or in privately negotiated transactions. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice. The Company is under no obligation to fulfill the entire amount of the stock buyback program approved by the Board.

About Vasomedical
Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Additional information is available on the Company's website at

Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipates", "believes", "could", "estimates", "expects", "may", "plans", "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in the conduct of clinical trials and other product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; continuation of the GEHC agreement; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250 /  

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
2. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
3. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at
4. Vasomedical, Inc. to Present Live Webcast at on February 7th
5. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
6. Vasomedical Common Stock Commences Trading on the OTCBB
7. Vasomedical Announces Financial Results for the Third Quarter of 2012
8. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
9. Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
10. Bovie Medical Corporation Announces Fiscal Year 2012 Financial Results
11. Cardiac Science announces definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc.
Post Your Comments:
(Date:10/13/2015)... Oct. 13, 2015   Rosa & Co. LLC ... Quantitative Systems Pharmacology (QSP)/ PhysioPD™ , today announced that ... a workshop at the QSP Congress Meeting ... Boston, MA.  The conference focuses on the ...  Dr. Friedrich,s workshop is entitled "Using Mechanistic Physiological Models ...
(Date:10/13/2015)... , Oct. 13, 2015 China ... or " China Jo-Jo "), a leading China-based retail, ... products through its own online and retail pharmacies, announced ... Company,s official branded online pharmacy through , ... was a record 25%. China Jo-Jo,s ...
(Date:10/13/2015)... 13, 2015  Yesterday Congresswoman Renee Ellmers ... manufacturing site located in Holly Springs, NC ... produced Flucelvax ® (Influenza Vaccine) using cell-culture technology, a ... start-up and is not reliant on chicken eggs. 1,2 ... influenza vaccines business of Novartis AG in the US, ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Dr. Poneh Ghasri, ... Today on September 18, 2015. The research, which was conducted at the Dental Institute ... and colleagues, show connections between stress during pregnancy and future dental health in the ...
(Date:10/13/2015)... ... October 13, 2015 , ... Leading Internet marketing ... launched "Publish Academy" training course . Singal's new program, in which he ... and marketers around the Internet are weighing in with reviews. , "Considering the ...
(Date:10/13/2015)... ... , ... Scientists in Seattle and Vancouver compared the diagnostic value of lung ... Surviving Mesothelioma has just posted an article on the new research. Click here ... the University of British Columbia found that certain genetic alterations were seen just as ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... School of Nursing. Dr. McLeod—who earned her Doctor of Nursing Practice from the ... that has spanned four decades. , Dr. McLeod’s long and successful nursing practice ...
(Date:10/13/2015)... ... 13, 2015 , ... Breathing is one of the human ... According to T’ai Chi (also spelled “Taiji”) and Qigong Grand-masters Steven Aung, MD, ... with the 7,000 year old tradition they teach, can improve health, increase energy ...
Breaking Medicine News(10 mins):